Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccination immunogenicity and tolerability in inflammatory bowel disease patients with or without immunosuppressive therapy
2009-014825-18Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Seroprotection rate. Started Aug 2009; status: active.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-014825-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014825-18.